Tizanidine
- Product NDC
- 68788-6444
- 11-digit product format
- 687886444
- Labeler code
- 68788
- Product ID
- 68788-6444_cc7b1fca-7a2a-4e89-8c57-58947b5fb32b
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Tizanidine
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Preferred Pharmaceuticals Inc.
- Application
- ANDA076416
- Marketing category
- ANDA
- Marketing start
- 2016-08-01
- Marketing end
- 0000-00-00
- Substance
- TIZANIDINE HYDROCHLORIDE
- Active strength
- 2 mg/1
- Pharmacologic classes
- Adrenergic alpha2-Agonists [MoA],Central alpha-2 Adrenergic Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 68788-6444-0 | 68788644400 | 120 TABLET in 1 BOTTLE (68788-6444-0) | 120 tablet | 2016-08-01 | 0000-00-00 | No | No | Current |
| 68788-6444-1 | 68788644401 | 100 TABLET in 1 BOTTLE (68788-6444-1) | 100 tablet | 2016-08-01 | 0000-00-00 | No | No | Current |
| 68788-6444-3 | 68788644403 | 30 TABLET in 1 BOTTLE (68788-6444-3) | 30 tablet | 2016-08-01 | 0000-00-00 | No | No | Current |
| 68788-6444-6 | 68788644406 | 60 TABLET in 1 BOTTLE (68788-6444-6) | 60 tablet | 2016-08-01 | 0000-00-00 | No | No | Current |
| 68788-6444-9 | 68788644409 | 90 TABLET in 1 BOTTLE (68788-6444-9) | 90 tablet | 2016-08-01 | 0000-00-00 | No | No | Current |